Last month President Trump vowed to ban the use of the Chinese social media giant domestically if a US enterprise didn't acquire it in 45-days. The Trump administration is concerned that TikTok (and in turn, the Chinese government) knows too much about its 80 million US users.
There has been a slew of eclectic bidders, including Microsoft (MSFT - Free Report) , Walmart (WMT - Free Report) , Twitter , and Oracle (ORCL - Free Report) .
Beijing's latest export restriction on intellectual property threw a wrench into recent negotiations. This has risen the question of whether TikTok's proprietary algorithm could be included in the deal. Without TikTok's underlying algorithm, the value added to an acquirer diminishes significantly.
I believe the new Chinese restriction frightened away bidders granting Oracle the bid.
The specifics of the arrangement are still unknown. According to those familiar with the deal, Oracle is approaching this as more of a partnership than an acquisition.
Despite the relatively high level of uncertainty associated with the agreement, ORCL is up over 4% in trading today.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Last month President Trump vowed to ban the use of the Chinese social media giant domestically if a US enterprise didn't acquire it in 45-days. The Trump administration is concerned that TikTok (and in turn, the Chinese government) knows too much about its 80 million US users.
There has been a slew of eclectic bidders, including Microsoft (MSFT - Free Report) , Walmart (WMT - Free Report) , Twitter , and Oracle (ORCL - Free Report) .
Beijing's latest export restriction on intellectual property threw a wrench into recent negotiations. This has risen the question of whether TikTok's proprietary algorithm could be included in the deal. Without TikTok's underlying algorithm, the value added to an acquirer diminishes significantly.
I believe the new Chinese restriction frightened away bidders granting Oracle the bid.
The specifics of the arrangement are still unknown. According to those familiar with the deal, Oracle is approaching this as more of a partnership than an acquisition.
Despite the relatively high level of uncertainty associated with the agreement, ORCL is up over 4% in trading today.
Breakout Biotech Stocks with Triple-Digit Profit Potential
The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.
Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.
See these 7 breakthrough stocks now>>
Zacks Names "Single Best Pick to Double"
From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.
It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.
This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.
Free: See Our Top Stock and 4 Runners Up >>
Get the latest research report on MSFT - FREE
Get the latest research report on WMT - FREE
Get the latest research report on ORCL - FREE